The Everything Blogger

Micromax is all geared up to unveil the In series phones in India on 3 November. Now the company took to Twitter to share the same with a short clip that highlighted two more features of the device.  The clip was posted alongside the caption, "India is gearing up to game on with the ultimate performance. And we have the perfect processor for that. Share the screenshot to tell us which one you think it is. #INMobiles unveiling on 3rd Nov, 12 noon." The clip highlights the presence of MediaTek Helio G35 and Helio G85 on the Micromax In series phones. Microsoft had on 16 October announced that it is planning to launch a new smartphone in India soon. Micromax co-founder Rahul Sharma had in a short video on Twitter talked about the company's journey till now, including the time when the Chinese smartphone makers overtook the competition leading to a drop in the sale of Micromax smartphones. According to a previous report, the upcoming Micromax series in India will have multipl

Realme is on a launch spree, the company has launched 10 different smartphones in the last 100 days in India. Earlier today, Realme India CEO, Madhav Sheth took it to twitter to ask the opinion of Realme fans and users on the MediaTek Dimensity processor. Realme, under its portfolio, has various smartphones powered by Media Dimensity SoCs but all those smartphones are exclusive to the Chinese market as of now. Realme V5, Realme V3, Realme X7, Realme X7 Pro, and the recently launched Realme Q2, Realme Q2 Pro, and Realme Q2i are the Realme smartphones that pack MediaTek Dimensity SoC under the hood. An hour later, Mr. Sheth cleared some air and hinted towards the arrival of Realme X7 series in India. To recall, the Realme X7 series, including Realme X7 and Realme X7 Pro launched in China last month. These devices look similar to the Realme 7 Pro, but come with a different paint job. Detailed specs of Realme X7 and X7 Pro can be found  here. Are you excited about Dimensity Chipset Launch

A recent study has found that nitric oxide, a cell-signaling molecule that the body produces naturally, could be a potential treatment for coronavirus infection until a vaccine arrives. There is no specific medicine or drug formula that checks the spread of SARS-CoV-2. The only antiviral treatment currently approved is giving doses of remdesivir to Covid-19 patients requiring hospitalisation. Remdesivir was originally developed for treatment of Ebola, another virus-generated infectious illness. It was understood to shorten the recovery time of hospitalised Covid-19 patients. However, the World Health Organisation (WHO) has now said remdesivir neither shortens the stay of Covid-19 patients in hospital nor reduces the mortality among those infected by SARS-CoV-2 coronavirus. This is discouraging news for the world, which is finding it difficult to get beyond this debilitating virus. However, a recent study has found a new solution that can be as effective as an antiviral treatment for Co

Yamaha have just announced that Valentino Rossi would not be able to compete in this weeks Aragon MotoGP due to Covid-19. He has been detected Covid Positive today. This comes with huge disappointment to his followers all round the globe. We hope for his well being and quick recovery. Hope he gets well soon. Statement from Yamaha: Yamaha Motor Co., Ltd. and Yamaha Motor Racing Srl regret to announce that Valentino Rossi will be unable to attend this weekend’s Gran Premio de Aragón. BACKGROUND INFORMATION - On Sunday 11th October, Rossi left the Le Mans circuit and travelled back to his home in Tavullia, Italy. - On Tuesday 13th October, Rossi underwent the usual PCR (Polymerase Chain Reaction) test, which is compulsory for those who visit their homes in between races. The result was available the next day and it was negative. - On Wednesday 14th October, Rossi was feeling fully fit and he trained at home without any symptoms or inconveniences. - On Thursday 15th October, he woke up in

Last 3 Race Weekends have been nothing less than distaster/heartbreaks for Yellow Army and Valentino Rossi alike. While The Doctor seemed pretty confident on Saturday's, he crashed on Sunday's. But the question that arises here is why so frequent falls? Simon Patterson has given pretty good analysis about it. Have a read. Since his return to Yamaha in 2013, Valentino Rossi has built a new style of MotoGP career for himself, challenging at the front of the championship not through outright speed but through consistency and being close to podium contention nearly every weekend. In fact, that consistency has become such a Rossi trait that it almost handed him his last championship success in 2015 – a year where he took four wins to Jorge Lorenzo’s seven and Marc Marquez’s five but managed to keep the fight going until the final round. However, that reliable form has deserted him in recent rounds this year, with Sunday’s crash out of the French Grand Prix marking his third DNF in t

Fabio Quartararo admits he “can’t replace” Valentino Rossi when the Frenchman steps up to the factory Yamaha squad in 2021 and is simply “taking his bike”. Nine-time grand prix motorcycle world champion Rossi will take Quartararo’s place at Petronas Yamaha next season, after a one-year deal with the Malaysian outfit and Yamaha was announced last weekend.  Yamaha moved to sign Quartararo amidst keen interest from Ducati on the 2019 rookie sensation, with Rossi’s original plans to assess his performances in the opening rounds before taking a decision on his future forcing him to be moved out of the works squad.  Quartararo’s deal with Yamaha to partner Maverick Vinales at the factory team runs through to 2022. Also read:  Why Rossi is called "The Doctor"? In an exclusive interview with Motorsport.com, Quartararo says he was “pleased” back in January that Yamaha believed in him for its future – but feels “nobody can touch” Rossi’s “place”.  “I was quite surprised because we make